Wall Street indexes climbed to two-week highs, led by tech stocks, as optimism about AI’s potential benefits overshadowed concerns about disruption and costs. Nvidia’s strong earnings fueled the rally, with the Nasdaq showing the largest percentage gain. Investors are weighing existential AI risks against potential returns.
Liraglutide still a ‘decent market’ despite Novo’s price moves: Siddharth Mittal, Biocon
Biocon CEO Siddharth Mittal outlines the company’s strategy in the competitive GLP-1 market. Focusing on liraglutide’s launch in the US and Europe, he highlights opportunities